Supernus

SUPN · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

Reported earnings 9 days ago

Qelbree Total Prescriptions

253.74K

Previous year: 215.04K

Previous year: $69.3M

+85.3%

Total Assets

$1.45B

Previous year: $1.37B

+6.2%

Loading...

Supernus

Unlock previous datapoints

Upgrade

Supernus

Unlock previous datapoints

Upgrade

Supernus Revenue by Segment

Revenue by Segment

Qelbree Revenue

CapyFin.com

GOCOVRI Revenue

CapyFin.com

APOKYN Revenue

CapyFin.com

Trokendi XR Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

Oxtellar XR Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

ONAPGO Revenue

CapyFin.com

Other Product Sales Revenue

CapyFin.com

ZURZUVAE Collaboration Revenue

CapyFin.com

Royalties & Licensing Revenue

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$3.13B

P/E Ratio

135.90

Sector

N/A

Industry

N/A

52-Week High

$56.8

52-Week Low

$30.2

Qelbree Total Prescriptions

253.74K

ONAPGO Prescribers

540

ONAPGO Enrollments

1.8K

Products

Get in Touch

Resources

Supernus

Supernus

Supernus

Supernus Revenue by Segment

Revenue by Segment

Qelbree Revenue

GOCOVRI Revenue

APOKYN Revenue

Trokendi XR Revenue

Oxtellar XR Revenue

ONAPGO Revenue

Other Product Sales Revenue

ZURZUVAE Collaboration Revenue

Royalties & Licensing Revenue

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics